Skip to content

Amarin Corp Plcuk

AMRN· NasdaqCore metricsCIK 897448

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -0.43%
Market cap
$4.91B
421.63M shares
Filings
1,015
$39.55M
Q3 2026−6.5% FY25 yoy
$245.00K
Q3 2026N/M FY25 yoy
-$2.36M
Q3 2026N/M FY25 yoy
-$22.00M
FY 2020derivedN/M FY20 yoy
$0.00
Q3 2026N/M FY25 yoy
$156.51M
Q3 2026+11.3% FY25 yoy
$4.91B
—
27.9×
11.0×
—
—

Twelve months to Sep 30, 2026 · derived

Price

$11.6427.66%$4.45past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$213.65MFY 2025
$614.06M0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$213,646,000reported
FY 20242024-12-31$228,614,000reported
FY 20232023-12-31$306,911,000reported
FY 20222022-12-31$369,193,000reported
FY 20212021-12-31$583,187,000reported
FY 20202020-12-31$614,060,000reported
FY 20192019-12-31$429,755,000reported
FY 20182018-12-31$229,214,000reported
FY 20172017-12-31$181,104,000reported
FY 20162016-12-31$130,084,000reported
FY 20152015-12-31$81,756,000reported
FY 20142014-12-31$54,202,000reported

Capital returns

Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2015—$194.00K$194.00K—183.40M sh+5.0%—

Segments

Products
Revenue by Products, FY2018 to FY2025FY2018Product Revenue, Net · FY2018 · $228.37MLicensing and Royalty Revenue · FY2018 · $843.00KFY2019Product Revenue, Net · FY2019 · $427.39MLicensing and Royalty Revenue · FY2019 · $2.36MFY2020Product Revenue, Net · FY2020 · $607.03MLicensing and Royalty Revenue · FY2020 · $7.04MFY2021Product Revenue, Net · FY2021 · $580.32MLicensing and Royalty Revenue · FY2021 · $2.87MFY2022Product Revenue, Net · FY2022 · $366.51MLicensing and Royalty Revenue · FY2022 · $2.68MFY2023Product Revenue, Net · FY2023 · $285.30MLicensing and Royalty Revenue · FY2023 · $21.61MFY2024Product Revenue, Net · FY2024 · $204.59MLicensing and Royalty Revenue · FY2024 · $24.02MFY2025Product Revenue, Net · FY2025 · $182.75MLicensing and Royalty Revenue · FY2025 · $30.89M
LineFY2025ShareChange
Product Revenue, Net$182.75M86%−10.7%
Licensing and Royalty Revenue$30.89M14%+28.6%
Total$213.65M

From the 10-K filed Mar 2, 2026AMRN

Pharmaceutical preparations

Amarin Corp Plcuk is the 84th largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Amarin Corp Plcuk · CIK 897448 · Engraved from SEC EDGAR